Clinical trial · Interventional
Transgender and Gender Diverse Individuals Screening for Breast Cancer
Transgender and GENdEr diverSe Individuals Screening for Breast Cancer: the GENESIS Study
NCT06347393CI-TRIAL-00087156GENESISactive not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this multicentric prospective study is to evaluate the incidence of Breast Cancer in transgender and gender-diverse population.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mammography and Breast Ultrasound | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Observational Prospective Cohort
- description
- Mammography and breast ultrasound
- interventionNames
- Diagnostic Test: Mammography and Breast Ultrasound
Primary outcomes (1)
- measure
- Incidence of Breast Cancer
- timeFrame
- 1 year
- description
- The incidence of BC in a selected population of transgender and gender-diverse individuals.
Secondary outcomes (1)
- measure
- The adherence rate to the screening
- timeFrame
- 1 year
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Transgender and gender-diverse individuals ≥18 years old who meet the ACR inclusion criteria * Signed Informed Consent Exclusion Criteria: * Refuse to sign Informed Consent
References
Publications (0)
Data not yet available
No reference posted for this study.